Watch and learn the fate of shortie !!

https://youtu.be/yBC5RJd1J9w

TopGlove IPO price RM2.70 March 2001

2,000 units X RM2.70= RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units X RM 6.50 = RM 1,589,952

Trust this chart tell everything ~~ Patient paid off
Still a millionaire !!

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 10% for FY21 with the current price

6th Jan 2020 Top Glove AGM Summary
1. ASP in Q2FY21 is expected 30% higher than Q1FY21. The whole industry players in gloves manufacturing agreed that the ASP will remain strong for year 2021.

2. Delivery period increase from 30~40 days previous to 560 days and 370 days for nitrile and natural rubber gloves respectively. Note: Nitrile and natural rubber gloves comprises of around 90% of Top Glove revenue in FY20.

3. US gloves stockpile reduced from 16.9 billion pieces to 2 billion pieces in October 2020.

4. Some Top Glove customer stockpile for gloves reduced from 2~3 months to 1~2 weeks.

5. Top Glove is exporting gloves to 195 countries currently.

6. Top Glove has enough raw material for continuous manufacturing of gloves.

7. Top Glove expects new players in gloves manufacturing facing issues from factory installing, workers and raw material issues.

8. Dividend payout for Q2, Q3 and Q4FY21 will be 70% on PATAMI.

9. Reason for share buyback (SBB) is because Top Glove thinks their company is undervalued at the purchased price and expects better return than putting into FD which gives 2% only. The amount of SBB is only 2.15% from the allowed 10% threshold.

10. Top Glove has 4 billion cash as of 31 Dec 2020.

11. US Border issues will be resolved when the independent international consultant verified the hostels and accommodation meets the required of Workers Housing Act 446.

12. All Top Glove factories that has been affected by Covid-19 lockdown has been resumed operations as of 20 Dec 2020. The lockdown is expected to impact 4% of the total revenue and profit.

13. Top Glove is spending 100 million for next 3 years to build hostels for 7300 workers and using 95 million to acquire new apartments for 2700 workers.

14. Top Glove is moving towards automation direction which previously 1 million gloves need 8 workers and now only 1.6 workers.

15. Top Glove current factory utilization rate is 95%.

16. Malaysia will remain the focus ground of gloves manufacturing activities at the same time expanding their existing foreign manufacturing plant.

17. Top Glove Hong Kong listed is expected around mid 2021.

18. Top Glove aims to achieve Fortune500 by 2035 with an expected CAGR of 20%. Note: Top Glove current CAGR is 28%.

Try la dont wear glove when you are giving a jab !! See you get infected of HIV/Hepatitis or not !! Only So hai ignore all this protection!! When you get a jab, it enter to your blood stream in which the needle is exposed to your disease... why take the risk of not wearing the glove ?? Maybe those stubborn who ignore this protection, deserved to be infected and die!!

Plus ... Pls provoke, beg and trick all the shortie to short !! Caused once their 4% cap is matched, RSS will be out of play ...and TG will sure to fly and fly !!

There is a reason why glove manufacturer still have a year plus of order in hand with deposit received, even with the deployment of the vaccine !! Stop dreaming that Covid will end, once the vaccine is deployed !! Between, Biden had set aside USD$ 50B for covid testing in his stimulus budget ... That always tell you that covid is here to stay for a long long time !!

Now even the leader of the vaccine manufacturer know how to cover his as $ before everyone know the truth !! Wakaka ... Pitiful!!

Moderna CEO says the world will have to live with Covid ‘forever’

https://www.cnbc.com/2021/01/13/moderna-ceo-says-the-world-will-have-to-live-with-the-coronavirus-forever.html

All the hoper or optimism of the vaccine !! Pls la ... go get vaccinated first, then live to tell us all !! We will be waiting for you !! If you did not respond anymore, then we know what exactly happen to you !!

Coronavirus vaccine: Pfizer given protection from legal action by UK government

https://www.independent.co.uk/news/health/coronavirus-pfizer-vaccine-legal-indemnity-safety-ministers-b1765124.html?amp

Even the manufacturer are not confident of their own product !! Now, you believe their product ?!! Wakaka What a S U Cker you are !! So hai!!

You can’t sue Pfizer or Moderna if you have severe Covid vaccine side effects. The government likely won't compensate you for damages either

https://www.cnbc.com/2020/12/16/covid-vaccine-side-effects-compensation-lawsuit.html

Bulgaria Reports 4 Cases Of Side Effects From Pfizer Covid Vaccine.
www.ndtv.com/world-news/bulgaria-reports-4-cases-of-side-effects-from-...

Two NHS workers suffer allergic reaction to Pfizer vaccine.
https://www.google.com/amp/s/www.telegraph.co.uk/global-health/science...

Do you need more evidence?? FYI, there is a reason why US FDA and WHO only authorise it for emergency use and NOT official use !!

U.S. officials report more severe allergic reactions to COVID-19 vaccines.
https://www.google.com/amp/s/mobile.reuters.com/article/amp/idUSKBN29B...

Life is a gamble, right ?? Gamble to get imune or get lifetime side effect !!

COVID Vaccine Side Effects More Common After 2nd Dose.
www.boston.cbslocal.com/2021/01/05/covid-vaccine-side-effects-fever-re...

CDC reveals at least 21 Americans have suffered life threatening allergic reactions to Pfizer's COVID vaccine
www.dailymail.co.uk/health/article-9119029/amp/At-21-Americans-life-th...

Buying your own side effect ?? OR Coffin ?

Wife of 'perfectly healthy' Miami doctor, 56, who died of a blood disorder 16 days after getting Pfizer Covid-19 vaccine is certain it was triggered by the jab, as drug giant investigates first death with a suspected link to shot.
https://www.dailymail.co.uk/news/article-9119431/Miami-doctor-58-dies-...

4 volunteers develop FACIAL PARALYSIS after taking Pfizer Covid-19 jab, prompting FDA to recommend ‘surveillance for cases’.
https://www.rt.com/usa/509081-pfizer-vaccine-fda-bells-palsy-covid/

Good luck with the vaccine !!

75-year-old Israeli man dies 2 hours after getting Covid-19 vaccine.
https://www.israelnationalnews.com/News/News.aspx/293865

Hundreds of Israelis get infected with Covid-19 after receiving Pfizer/BioNTech vaccine.
https://www.rt.com/news/511332-israel-vaccination-coronavirus-pfizer/

Is the RSS 4% cap for the whole year round ?? Once touch, meaning you cannot rss for the whole year any more ?

Trust there is a potential here too to replicate history~~

JPM lawsuit for wrongdoing

https://www.cnbc.com/2020/09/29/jpmorgan-chase-to-pay-920-million-to-resolve-us-investigations-into-trading-practices-.html

6th Jan 2020 Top Glove AGM Summary
1. ASP in Q2FY21 is expected 30% higher than Q1FY21. The whole industry players in gloves manufacturing agreed that the ASP will remain strong for year 2021.

2. Delivery period increase from 30~40 days previous to 560 days and 370 days for nitrile and natural rubber gloves respectively. Note: Nitrile and natural rubber gloves comprises of around 90% of Top Glove revenue in FY20.

3. US gloves stockpile reduced from 16.9 billion pieces to 2 billion pieces in October 2020.

4. Some Top Glove customer stockpile for gloves reduced from 2~3 months to 1~2 weeks.

5. Top Glove is exporting gloves to 195 countries currently.

6. Top Glove has enough raw material for continuous manufacturing of gloves.

7. Top Glove expects new players in gloves manufacturing facing issues from factory installing, workers and raw material issues.

8. Dividend payout for Q2, Q3 and Q4FY21 will be 70% on PATAMI.

9. Reason for share buyback (SBB) is because Top Glove thinks their company is undervalued at the purchased price and expects better return than putting into FD which gives 2% only. The amount of SBB is only 2.15% from the allowed 10% threshold.

10. Top Glove has 4 billion cash as of 31 Dec 2020.

11. US Border issues will be resolved when the independent international consultant verified the hostels and accommodation meets the required of Workers Housing Act 446.

12. All Top Glove factories that has been affected by Covid-19 lockdown has been resumed operations as of 20 Dec 2020. The lockdown is expected to impact 4% of the total revenue and profit.

13. Top Glove is spending 100 million for next 3 years to build hostels for 7300 workers and using 95 million to acquire new apartments for 2700 workers.

14. Top Glove is moving towards automation direction which previously 1 million gloves need 8 workers and now only 1.6 workers.

15. Top Glove current factory utilization rate is 95%.

16. Malaysia will remain the focus ground of gloves manufacturing activities at the same time expanding their existing foreign manufacturing plant.

17. Top Glove Hong Kong listed is expected around mid 2021.

18. Top Glove aims to achieve Fortune500 by 2035 with an expected CAGR of 20%. Note: Top Glove current CAGR is 28%.

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 10% for FY21 with the current price

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

TopGlove IPO price RM2.70 March 2001

2,000 units X RM2.70= RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units X RM 6.50 = RM 1,589,952

Trust this chart tell everything ~~ Patient paid off
Still a millionaire !!

We know who wrote that JPM analysis!! Now, show your feeling to him !! Call, email or talk to him face to face!! He can comment on how he feel about TG, why cant we express our feeling toward his analysis!!

If still not enough !! Just let his family know as well ~~ Just make it simple and straightforward!!

Why la condemn JPM as a whole !! Just condemn the analyst who wrote the analysis... You know who wrote it and you know where is his position & contact !! Just pay him a visit or give him a courtesy call SO THAT you can really show him how you really feel !!

Got a feeling that tomorrow is going to be a memorable day !! The fact is today was a boring and reserved day where the interest volume is not huge and the shorting volume is at a minimal !! Trust something is brewing for either tomorrow or friday ~~

High Dividend !!
Record Breaking Revenue !!
Record Breaking Profit !!
Order in hand for the whole year !!
Glove demand to rise monthly for the whole year !!
ASP to spiked until first half of the year !!
High Cash in hand !!
Sukuk financial back up !!

What more do you want ?? All the good indicators for a matched

TopGlove IPO price RM2.70 March 2001

2,000 units X RM2.70= RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units X RM 6.50 = RM 1,589,952

Trust this chart tell everything ~~ Patient paid off
Still a millionaire !!

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 10% for FY21 with the current price

6th Jan 2020 Top Glove AGM Summary
1. ASP in Q2FY21 is expected 30% higher than Q1FY21. The whole industry players in gloves manufacturing agreed that the ASP will remain strong for year 2021.

2. Delivery period increase from 30~40 days previous to 560 days and 370 days for nitrile and natural rubber gloves respectively. Note: Nitrile and natural rubber gloves comprises of around 90% of Top Glove revenue in FY20.

3. US gloves stockpile reduced from 16.9 billion pieces to 2 billion pieces in October 2020.

4. Some Top Glove customer stockpile for gloves reduced from 2~3 months to 1~2 weeks.

5. Top Glove is exporting gloves to 195 countries currently.

6. Top Glove has enough raw material for continuous manufacturing of gloves.

7. Top Glove expects new players in gloves manufacturing facing issues from factory installing, workers and raw material issues.

8. Dividend payout for Q2, Q3 and Q4FY21 will be 70% on PATAMI.

9. Reason for share buyback (SBB) is because Top Glove thinks their company is undervalued at the purchased price and expects better return than putting into FD which gives 2% only. The amount of SBB is only 2.15% from the allowed 10% threshold.

10. Top Glove has 4 billion cash as of 31 Dec 2020.

11. US Border issues will be resolved when the independent international consultant verified the hostels and accommodation meets the required of Workers Housing Act 446.

12. All Top Glove factories that has been affected by Covid-19 lockdown has been resumed operations as of 20 Dec 2020. The lockdown is expected to impact 4% of the total revenue and profit.

13. Top Glove is spending 100 million for next 3 years to build hostels for 7300 workers and using 95 million to acquire new apartments for 2700 workers.

14. Top Glove is moving towards automation direction which previously 1 million gloves need 8 workers and now only 1.6 workers.

15. Top Glove current factory utilization rate is 95%.

16. Malaysia will remain the focus ground of gloves manufacturing activities at the same time expanding their existing foreign manufacturing plant.

17. Top Glove Hong Kong listed is expected around mid 2021.

18. Top Glove aims to achieve Fortune500 by 2035 with an expected CAGR of 20%. Note: Top Glove current CAGR is 28%.

ravin25 IT'S NOT LOOKING GOOD FOR THE PFIZER VACCINE. ⬇️⬇️

FROM THE CDC; 3,150 people vaccinated in ONE DAY are "unable to perform normal daily activities, unable to work" after vaccination.

This is a massive 2.7% of people who can no longer work after having the Pfizer vaccine.
https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2020-12/slides-12-19/05-COVID-CLARK.pdf

Portuguese health worker, 41, dies two days after getting the Pfizer covid vaccine as her father says he 'wants answers'
https://trib.al/eEWi66p

Mexican doctor hospitalized after receiving COVID-19 vaccine
https://www.reuters.com/article/health-coronavirus-mexico-vaccines-idUSKBN2970H3

Hundreds of Israelis get infected with Covid-19 after receiving Pfizer/BioNTech vaccine.
https://www.rt.com/news/511332-israel-vaccination-coronavirus-pfizer/

Wife of 'perfectly healthy' Miami doctor, 56, who died of a blood disorder 16 days after getting Pfizer Covid-19 vaccine is certain it was triggered by the jab, as drug giant investigates first death with a suspected link to shot.
https://www.dailymail.co.uk/news/article-9119431/Miami-doctor-58-dies-three-weeks-receiving-Pfizer-Covid-19-vaccine.html

75-year-old Israeli man dies 2 hours after getting Covid-19 vaccine.
https://www.israelnationalnews.com/News/News.aspx/293865

Death of Swiss man after Pfizer vaccine.
https://www.reuters.com/article/us-health-coronavirus-swiss-death-idUSKBN29413Y

88-year-old collapses and dies several hours after being vaccinated.
https://www.israelnationalnews.com/News/News.aspx/293952

Thousands negatively affected after getting Covid-19 vaccine.
https://m.theepochtimes.com/thousands-negatively-affected-after-getting-covid-19-vaccine_3625914.html

Hospital worker with no prior allergies in intensive care with severe reaction after Pfizer Covid vaccine.
https://metro.co.uk/2020/12/16/hospital-worker-in-intensive-care-after-suffering-severe-allergic-reaction-to-covid-vaccine-13763695/

4 volunteers develop FACIAL PARALYSIS after taking Pfizer Covid-19 jab, prompting FDA to recommend ‘surveillance for cases’.
https://www.rt.com/usa/509081-pfizer-vaccine-fda-bells-palsy-covid/

Investigation launched as 2 people die in Norway nursing home days after receiving Pfizer’s Covid-19 vaccine.
https://www.rt.com/news/511623-norway-covid19-vaccine-deaths/

Hundreds Sent to Emergency Room After Getting COVID-19 Vaccines
https://m.theepochtimes.com/hundreds-sent-to-emergency-room-after-getting-covid-19-vaccines_3644148.html

U.S. officials report more severe allergic reactions to COVID-19 vaccines.
https://www.google.com/amp/s/mobile.reuters.com/article/amp/idUSKBN29B2GS

NHS told not to give Covid vaccine to those with history of allergic reactions.
https://www.google.com/amp/s/amp.theguardian.com/world/2020/dec/09/pfizer-covid-vaccine-nhs-extreme-allergy-sufferers-regulators-reaction

COVID-19: Single vaccine dose leads to 'greater risk' from new coronavirus variants, South African experts warn
news.sky.com/story/amp/covid-19-single-vaccine-dose-leads-to-greater-risk-from-new-coronavirus-variants-south-african-experts-warn-12180837

CDC reveals at least 21 Americans have suffered life threatening allergic reactions to Pfizer's COVID vaccine
www.dailymail.co.uk/health/article-9119029/amp/At-21-Americans-life-threatening-anaphylaxis-receiving-Pfizers-vaccine-CDC-reveals.html

Woman experiences side effects of COVID-19 vaccine
www.everythinglubbock.com/news/local-news/woman-experiences-side-effects-of-covid-19-vaccine/amp/

COVID Vaccine Side Effects More Common After 2nd Dose.
www.boston.cbslocal.com/2021/01/05/covid-vaccine-side-effects-fever-reaction/amp/

Bulgaria Reports 4 Cases Of Side Effects From Pfizer Covid Vaccine.
www.ndtv.com/world-news/bulgaria-reports-4-cases-of-side-effects-from-pfizer-covid-vaccine-2347667%3famp=1&akamai-rum=off

Two NHS workers suffer allergic reaction to Pfizer vaccine.
https://www.google.com/amp/s/www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-vaccine-pfizer-nhs-oxford-covid-uk-cases/amp/
11/01/2021 11:26 PM

ASP to rised at 30% and higher capacity 5%
Last QTR PAT = RM 2.4 B X +30% X +5% = RM3.276 B PAT next quarter !! Pls be reminded !!

High Dividend !!
Record Breaking Revenue !!
Record Breaking Profit !!
Order in hand for the whole year !!
Glove demand to rise monthly for the whole year !!
ASP to spiked until first half of the year !!
High Cash in hand !!
Sukuk financial back up !!

What more do you want ?? All the good indicators for a matched

Overall review:-

EPF interested in buying again with ESG fulfillment
Crossed buying from recovery market sell off
Covid mutation in UK, may lead to potential epidemic
Vaccine faced production capacity limitation
Vaccine faced distribution issue
Vaccine had allergy effect
Vaccine do not have testing for long term side effect
Vaccine not recommended for under 16
Vaccine not recommended for pregnant mom
Covid to spike from now till end of Feb
ASP for glove to rise 20-30% in this quarter
Order in hand for FY21 and FY22 still in tag
Record breaking RM 3.5B PAT coming QR
Additional 10% capacity in the coming quarter
Worker act issue and accomodation to be settle this month
US Ban in final discussion, expected to be resume export in Jan
Management continue to buy in and provide support line
Glove demand expected to rise by 20-30% in FY21
Divident at least 10% for FY21 with the current price

TopGlove IPO price RM2.70 March 2001

2,000 units X RM2.70= RM5,400

Bonus issues:
2002 3:10 ==> 2,600 units
2003 2:5 ==> 3,640 units
2005 1:1 ==> 7,280 units
2007 2:5 ==> 10,192 units
2010 1:1 ==> 20,384 units
2016 1:1 ==> 40,768 units
2018 1:1 ==> 81,536 units
2020 2:1 ==> 244,608 units

244608 units X RM 6.50 = RM 1,589,952

Trust this chart tell everything ~~ Patient paid off
Still a millionaire !!

TG next quarter review:-

ESG fulfillment will prompt EPF acquisition
Additional 10% capacity = Increased Revenue
ASP to rises 20-30% = Approximately RM 3.5Billion PAT
Worker Accomodation to be settled in Jan
US Ban in final stages of discussion, should be lifted in FY21Q2
Demand for glove expected to rise 20-30% in FY21
Remained as a safe haven from political uncertainy
Remained as favourite to capitalise in Covid spike
Next dividend should be more than 16.5sen due to increased Revenue and PAT

6th Jan 2020 Top Glove AGM Summary
1. ASP in Q2FY21 is expected 30% higher than Q1FY21. The whole industry players in gloves manufacturing agreed that the ASP will remain strong for year 2021.

2. Delivery period increase from 30~40 days previous to 560 days and 370 days for nitrile and natural rubber gloves respectively. Note: Nitrile and natural rubber gloves comprises of around 90% of Top Glove revenue in FY20.

3. US gloves stockpile reduced from 16.9 billion pieces to 2 billion pieces in October 2020.

4. Some Top Glove customer stockpile for gloves reduced from 2~3 months to 1~2 weeks.

5. Top Glove is exporting gloves to 195 countries currently.

6. Top Glove has enough raw material for continuous manufacturing of gloves.

7. Top Glove expects new players in gloves manufacturing facing issues from factory installing, workers and raw material issues.

8. Dividend payout for Q2, Q3 and Q4FY21 will be 70% on PATAMI.

9. Reason for share buyback (SBB) is because Top Glove thinks their company is undervalued at the purchased price and expects better return than putting into FD which gives 2% only. The amount of SBB is only 2.15% from the allowed 10% threshold.

10. Top Glove has 4 billion cash as of 31 Dec 2020.

11. US Border issues will be resolved when the independent international consultant verified the hostels and accommodation meets the required of Workers Housing Act 446.

12. All Top Glove factories that has been affected by Covid-19 lockdown has been resumed operations as of 20 Dec 2020. The lockdown is expected to impact 4% of the total revenue and profit.

13. Top Glove is spending 100 million for next 3 years to build hostels for 7300 workers and using 95 million to acquire new apartments for 2700 workers.

14. Top Glove is moving towards automation direction which previously 1 million gloves need 8 workers and now only 1.6 workers.

15. Top Glove current factory utilization rate is 95%.

16. Malaysia will remain the focus ground of gloves manufacturing activities at the same time expanding their existing foreign manufacturing plant.

17. Top Glove Hong Kong listed is expected around mid 2021.

18. Top Glove aims to achieve Fortune500 by 2035 with an expected CAGR of 20%. Note: Top Glove current CAGR is 28%.